Cerebrospinal Fluid Immune Cell Alterations in Women With Neuropsychiatric Long COVID - Top-Institutions - MDSpire

Cerebrospinal Fluid Immune Cell Alterations in Women With Neuropsychiatric Long COVID

  • By

  • Benjamin Orlinick

  • Sameet Mehta

  • Lindsay McAlpine

  • Saba Khoshbakht

  • Sofia Fertuzinhos

  • Allison Nelson

  • Jennifer Chiarella

  • Bibhuprasad Das

  • Vansh Patel

  • Paraskevas Filippidis

  • Michael J Corley

  • Serena S Spudich

  • Shelli F Farhadian

  • September 8, 2025

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Neuroimmunology
    • Infectious Diseases
    • Neurology

  • #2

    Massachusetts General Hospital / Harvard Medical School
    Massachusetts General Hospital / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Neurology
    • Neuropsychiatry
    • Immunology

  • #3

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Neurology
    • Neuroimmunology
    • Infectious Diseases

  • #4

    National Institute of Neurological Disorders and Stroke (NINDS), NIH
    National Institute of Neurological Disorders and Stroke (NINDS), NIH

    Bethesda, MD

    Key Differentiators

    • Neurology
    • Neuroimmunology
    • Neuroscience Research

Original Source(s)

Cerebrospinal Fluid Immune Cell Alterations in Women With Neuropsychiatric Long COVID

  • by Benjamin Orlinick, Sameet Mehta, Lindsay McAlpine, Saba Khoshbakht, Sofia Fertuzinhos, Allison Nelson, Jennifer Chiarella, Bibhuprasad Das, Vansh Patel, Paraskevas Filippidis, Michael J Corley, Serena S Spudich, Shelli F Farhadian

  • September 8, 2025

Related Content

The CRISPR-powered Diagnostic SLEUTH

Novel DNA-guided system may support future RNA diagnostics and mutation detection

  • May 22, 2026

  • 2 min
Beyond recovery: long-term cardiovascular risks after severe COVID-19 requiring intensive care

Antibiotics May Not Help Mild COVID

A retrospective cohort study of more than 520,000 hospitalized patients found no clinically meaningful improvement in deterioration or mortality with early treatment targeting community-acquired pneumonia.